Daily Earnings Reports
📊 STOCKINSIGHT™ EARNINGS DASHBOARD — AUGUST 14, 2026
🇺🇸 Full Earnings Recap — All Major U.S.-Listed Reports
🌅 BEFORE MARKET OPEN
🥇 Sigma Lithium — SGML
Friday close: around $10.50
Day reaction: 🔴 ~−8.9%
Revenue: $54.7M
Estimate: $68.34M
Revenue Surprise: 🔴 −19.9%
EPS: −$0.02
Estimate: $0.23
EPS Surprise: 🔴 −$0.25
🔎 What drove the result?
The headline financials disappointed, but the operating performance was much stronger.
- Lithium concentrate sales: 24,400 tonnes
- Realized price: $2,089/t, up 17% QoQ
- Gross margin: 60%
- Operating margin: 32%
- Adjusted EBITDA margin: 47%, a company record
- Q2 production had previously exceeded guidance by 6%
The disconnect is important: production and margins improved dramatically, but reported revenue came in below the Street’s expectations.
Investor Read: 🟡 Operationally improving, but the revenue/EPS miss dominated the initial reaction.
Trade Setup: 🟡 Contrarian Watch / High Volatility (TMX Newsfile)
🥈 Americas Gold & Silver — USAS
Friday close: ~$5.28
Friday move: 🟢 +4.55%
Q2 Revenue: $46.3M
Revenue Growth: 🚀 +71% YoY
Net Income: swung to profit
Q2 Silver Production: 665,000 oz
FY2026 Silver Guidance: 3.2M–3.6M oz
Guidance: 🟢 Reaffirmed
🔎 What drove the result?
- Higher silver prices
- Stronger production at Cosalá
- Progress at the Galena Complex
- Antimony and other by-product contributions
- Operating cash flow improved substantially
- Full-year production guidance maintained
Investor Read: This was much cleaner than the Sigma report. Revenue growth, operational execution and maintained production guidance all supported the shares.
Trade Setup: 🟢 Bullish / Momentum (Benzinga)
3️⃣ Digi Power X — DGXX
Friday reaction: 🔴 Sharp sell-off
Q2 Revenue: $6.6M
GAAP Net Loss: $14.4M
Adjusted EBITDA: +$3.3M
AI Compute Revenue: $1.1M
🚀 The real story
Digi Power is transitioning from crypto mining toward AI data-center infrastructure.
The company now has:
- First AI-compute revenue
- GPU rental revenue
- $1.1B contracted AI-infrastructure revenue
- Target annualized revenue run-rate of $250M–$300M by Q3 2027
- Approximately $142M cash at June 30
💡 Investor Read
The current income statement still looks weak, but the investment thesis is increasingly about the AI infrastructure pipeline, not legacy mining.
The market nevertheless sold the stock, highlighting the gap between future contracted opportunity and current revenue.
Trade Setup: 🟡 Speculative AI Infrastructure (Stock Titan)
4️⃣ Outlook Therapeutics — OTLK
EPS: −$0.09
Estimate: −$0.08
EPS Surprise: 🔴 −$0.01
Revenue: approximately $0.01M
Estimate: ~$0.97M
Revenue Surprise: 🔴 Large Miss
💊 But earnings aren’t the main story
The important development is LYTENAVA, the company’s ophthalmic bevacizumab.
The FDA has approved LYTENAVA for wet AMD, and management is preparing a U.S. commercial launch before year-end 2026.
The company is working on:
- Payer engagement
- Commercial supply
- Reimbursement
- HCPCS code application
- U.S. launch infrastructure
It also raised capital to fund commercialization.
Investor Read: Financially weak, strategically significant. This is a commercial-launch story, not an earnings-multiple story.
Trade Setup: 🟡 Event-Driven / Very High Risk (GlobeNewswire)
5️⃣ Cosan — CSAN
EPS: $0.40
Estimate: $0.01
EPS Surprise: 🚀 +$0.39
Revenue: $2.08B
Estimate: $998.5M
Revenue Surprise: 🚀 +108%
🔎 Key Driver
The Brazilian energy/infrastructure group delivered a massive EPS and revenue beat.
The headline numbers were distorted by the group’s complex portfolio and accounting, so investors need to look beyond the headline EPS.
Investor Read: 🟢 Strong earnings surprise, although the conglomerate structure makes the result harder to value on a simple earnings multiple.
Trade Setup: 🟢 Bullish / Event Watch (MarketBeat)
6️⃣ MS&AD Insurance Group — MSADY
Q1 FY2026 result: 🟢 Growth continued
MS&AD reported continued growth in its first-quarter results, while its U.S. insurance operations have been expanding rapidly.
🔎 Key Driver
The U.S. business increased direct premiums written by 31.8% to $175M in the latest industry ranking.
Investor Read: More of a steady financial compounder story than a high-volatility earnings trade.
Trade Setup: 🟢 Moderately Bullish (GuruFocus)
🌙 AFTER MARKET CLOSE
🥇 Nu Holdings — NU
Friday close: ~$15.35
Friday move: 🚀 +10%
Revenue: $5.51B
Estimate: $5.45B
Revenue Surprise: 🟢 +$60M
EPS: $0.22
Estimate: $0.19
EPS Surprise: 🟢 ~+16%
Net Income: >$1B
🔎 What drove the result?
This was one of the strongest financial reports of the day.
- Revenue growth around 50% YoY
- First quarterly net income above $1B
- Customer expansion remained strong
- Credit metrics remained healthy
- Net interest margin remained robust
- Management emphasized risk-adjusted profitability
- Mexico remains a major long-term growth opportunity
- AI is increasingly being used within the company’s operating model
Investor Read: The market liked the combination of growth + profitability + balance-sheet strength.
Trade Setup: 🟢 Strong Bullish / Buy-on-Dip
The stock opened approximately 13% higher and remained around 10% higher later in the session. (Yahoo Finanzen)
🥈 Credicorp — BAP
Friday close: around $375
EPS: $7.29
Estimate: $7.20
EPS Surprise: 🟢 +$0.09
Revenue: $1.79B
Estimate: $1.72B
Revenue Surprise: 🟢 +$71M
🔎 Key Drivers
- Revenue growth of approximately 13.5% YoY
- EPS growth approximately 16.8% YoY
- Strong Peruvian financial franchise
- Continued profitability
- Healthy credit environment
Investor Read: A solid beat on both EPS and revenue. Less explosive than NU, but arguably a cleaner traditional financial result.
Trade Setup: 🟢 Bullish / Quality Financial (Reddit)
🥉 QXO — QXO
Q2 Revenue: $3.25B
Prior year: $1.91B
Revenue Growth: 🚀 +70%
EPS: $0.08
Net Loss: $55M
Adjusted EBITDA: approximately $272M
🔎 The real story
QXO is rapidly transforming through acquisitions.
- Kodiak contributed approximately $595M of Q2 sales
- Beacon was included for a full quarter
- Gross profit reached $803M
- Gross margin reached approximately 24.7%
- TopBuild acquisition closed July 1, meaning its contribution wasn’t included in Q2
- Long-term target remains approximately $50B annual revenue
⚠️ The Risk
Debt and integration are becoming increasingly important.
QXO’s long-term debt exceeded $6B after the acquisition activity.
Investor Read: The market is valuing QXO primarily on its future consolidated earnings power, not today’s GAAP EPS.
Trade Setup: 🟡 High-Risk Growth / Acquisition Story (Stock Titan)
4️⃣ StoneCo — STNE
Revenue: $709.4M
Estimate: $731.2M
Revenue Surprise: 🔴 −3.0%
EPS: $0.47
Estimate: $0.46
EPS Surprise: 🟢 +2.2%
Friday reaction: 🔴 ~−6%
🔎 Key Drivers
StoneCo continues to benefit from Brazil’s digital-payment adoption, but the quarter showed a familiar issue:
profitability is holding up better than top-line expectations.
Investor Read: The EPS beat wasn’t enough to overcome the revenue miss.
Trade Setup: 🔴 Bearish / Wait for Revenue Reacceleration (Reddit)
5️⃣ Globant — GLOB
Revenue: $614.4M
Estimate: ~$612.9M
Revenue Surprise: 🟢 ~+0.2%
Adjusted EPS: $1.40
Estimate: $1.43
EPS Surprise: 🔴 −2.1%
After-hours reaction: 🔴 ~−13%
🔎 Why investors sold it
The problem wasn’t the current-quarter revenue.
It was forward growth.
Q3 Revenue Guidance: $607M–$615M
Street: ~$626M
Q3 EPS Guidance: $1.43–$1.53
Street: ~$1.59
That tells investors the AI-driven transformation story is not yet translating into the acceleration they were expecting.
Trade Setup: 🔴 Bearish (Reddit)
6️⃣ York Space Systems — YSS
Revenue: $92.55M
Estimate: ~$92.0M
Revenue Surprise: 🟢 Beat
EPS: −$0.31
Estimate: −$0.13
EPS Surprise: 🔴 −$0.18
Revenue Growth: +10.4% YoY
🔎 Key Drivers
The space-infrastructure business continues to grow, but the company remains loss-making.
The earnings issue was primarily profitability, not sales.
Trade Setup: 🔴 Bearish / High Risk (Reddit)
7️⃣ 4D Molecular Therapeutics — FDMT
Revenue: $3.78M
Estimate: $2.48M
Revenue Surprise: 🟢 +52%
EPS: −$1.04
Estimate: −$1.02
EPS Surprise: 🔴 −$0.02
🔎 Key Drivers
The company remains primarily a clinical-development story.
The revenue beat is positive, but investors will focus on:
- Clinical-program progress
- Cash runway
- Pipeline milestones
- Potential partnerships
Trade Setup: 🟡 Speculative Biotech
8️⃣ Nektar Therapeutics — NKTR
Revenue: $10.13M
Estimate: ~$10.54M
Revenue Surprise: 🔴 −$0.41M
EPS: −$1.23
Estimate: −$2.04
EPS Surprise: 🟢 +$0.81
🔎 Key Drivers
Nektar produced a substantial EPS beat despite weaker revenue.
The important variables remain pipeline execution and cash consumption, rather than quarterly revenue.
Trade Setup: 🟡 Speculative / Catalyst Driven (Reddit)
9️⃣ KinderCare Learning — KLC
Revenue: $697.5M
Estimate: $697.8M
Revenue Surprise: 🟡 Essentially In Line
EPS: $0.08
Estimate: $0.10
EPS Surprise: 🔴 −20%
Revenue Growth: approximately flat YoY
Investor Read
The company remains exposed to:
- Childcare demand
- Labor costs
- Enrollment
- Wage inflation
The quarter provided little evidence of accelerating growth.
Trade Setup: 🔴 Cautious
🔟 Solana Company — HSDT
Friday close: $1.70
After-hours: $1.71
Regular-session move: 🔴 −5.56%
After-hours: 🟢 +0.59%
Revenue: $2.5M
Estimate: $2.9M
Revenue Surprise: 🔴 −13.8%
Gross Profit: $2.4M
Gross Margin: approximately 97%
🔎 Key Drivers
Almost all revenue came from staking income on SOL holdings.
The company also reported a much larger loss because of expenses associated with its transition into a digital-asset treasury/infrastructure business.
Investor Read: The market initially disliked the revenue miss, but the near-100% gross margin and Solana exposure provide the speculative bull case.
Trade Setup: 🟡 Crypto / High-Risk Speculative (Investing.com)
1️⃣1️⃣ Bally’s — BALY
Revenue: $792.23M
Estimate: $789.89M
Revenue Surprise: 🟢 +$2.34M
EPS: −$2.41
Estimate: −$1.08
EPS Surprise: 🔴 −$1.33
After-hours reaction: 🟢 ~+3.1% to $13.90
🔎 Why the stock rose despite the EPS miss
Revenue exceeded expectations, and investors appear to be looking beyond the quarterly loss toward the company’s casino/online gaming portfolio and strategic positioning.
Still, the $2.41 loss versus a $1.08 expected loss is a significant warning.
Trade Setup: 🟡 Speculative / Event Driven (MarketBeat)
1️⃣2️⃣ HIVE Digital — HIVE
Report: After close
HIVE’s fiscal Q1 2027 report was released after the market close, with investors focused heavily on the company’s transition from Bitcoin mining toward AI/HPC data-center infrastructure.
The company operates data centers across Canada, Sweden and Paraguay and has been building out AI/HPC capacity.
Key Catalyst: AI/HPC revenue growth versus Bitcoin-mining economics.
Important: I am not assigning an after-hours percentage here without a sufficiently reliable verified quote, rather than inventing one.
Trade Setup: 🟡 Speculative AI/Crypto Infrastructure (TMX Newsfile)
📊 AUGUST 14 — COMPLETE SCORECARD
| Stock | Timing | Price Reaction | EPS Surprise | Revenue Surprise | Main Driver | Setup |
|---|---|---|---|---|---|---|
| SGML | BMO | 🔴 ~−8.9% | 🔴 −$0.25 | 🔴 −19.9% | Record margins | 🟡 |
| USAS | BMO | 🟢 +4.55% | 🟢 | 🟢 +71% YoY | Silver production/prices | 🟢 |
| DGXX | BMO | 🔴 Sharp drop | 🔴 | 🟡 | AI transition | 🟡 |
| OTLK | BMO | 🟡 | 🔴 −$0.01 | 🔴 Large miss | LYTENAVA launch | 🟡 |
| CSAN | BMO | 🟢 | 🚀 +$0.39 | 🚀 +108% | Energy/infrastructure | 🟢 |
| MSADY | BMO | 🟡 | 🟢 | 🟢 | Insurance growth | 🟢 |
| NU | AMC | 🚀 ~+10% | 🟢 +~16% | 🟢 +~$60M | Fintech profitability | 🟢 |
| BAP | AMC | 🟢 | 🟢 +$0.09 | 🟢 +$71M | Banking | 🟢 |
| QXO | AMC | 🟢/🟡 | 🟡 | 🟢 +70% YoY | Acquisitions | 🟡 |
| STNE | AMC | 🔴 ~−6% | 🟢 | 🔴 ~−3% | Payment growth | 🔴 |
| GLOB | AMC | 🔴 ~−13% AH | 🔴 | 🟢 ~+0.2% | Weak guidance | 🔴 |
| YSS | AMC | 🔴 | 🔴 −$0.18 | 🟢 | Space growth | 🔴 |
| FDMT | AMC | 🟡 | 🔴 | 🟢 +52% | Clinical pipeline | 🟡 |
| NKTR | AMC | 🟡 | 🟢 +$0.81 | 🔴 | Pipeline/cash | 🟡 |
| KLC | AMC | 🔴/🟡 | 🔴 −20% | 🟡 | Enrollment/costs | 🔴 |
| HSDT | AMC | 🔴 −5.56% / 🟢 +0.59% AH | 🟡 | 🔴 −13.8% | SOL staking | 🟡 |
| BALY | AMC | 🟢 ~+3.1% AH | 🔴 −$1.33 | 🟢 +$2.34M | Gaming | 🟡 |
| HIVE | AMC | ⚠️ No verified AH % | — | — | AI/HPC + Bitcoin | 🟡 |
🏆 Best Reports
🥇 NU — Best Overall
The cleanest combination of revenue growth, EPS beat, profitability and strong stock reaction.
🥈 USAS — Best Metals Report
71% revenue growth + maintained production guidance + positive price reaction.
🥉 BAP — Best Traditional Financial
Both EPS and revenue beat expectations with strong year-over-year growth.
🚀 CSAN — Biggest Fundamental Surprise
The EPS and revenue beats were exceptionally large, although the conglomerate structure makes the numbers more difficult to interpret.
🚨 Biggest Disappointments
🔴 GLOB
The current quarter was close to expectations, but forward guidance was the problem. That’s why the stock reaction was so severe.
🔴 SGML
Excellent operational margins but a significant revenue/EPS miss.
🔴 YSS
Revenue beat, but the EPS miss showed that growth isn’t yet translating into sufficient profitability.
🔴 STNE
EPS beat couldn’t overcome the revenue miss and weaker market expectations.
🔎 What Mattered Most on August 14
🤖 AI Infrastructure
DGXX and HIVE demonstrate the continuing investor appetite for companies transitioning from crypto/mining or traditional infrastructure into AI/HPC data centers.
But the market is becoming more demanding: investors want to see actual revenue, not just future contracts.
💰 Financials
NU and BAP were among the strongest reports because their earnings were supported by real profitability and improving operating metrics, rather than simply an aggressive future growth story.
⛏️ Metals
USAS vs. SGML was an interesting contrast.
USAS delivered strong revenue growth and maintained guidance, while SGML delivered record margins but missed revenue expectations.
💻 Software
GLOB showed why guidance matters more than the headline EPS number. A small current-quarter miss became a major sell-off because management’s forward outlook was below expectations.
🎯 STOCKINSIGHT™ TRADE RANKING
| Rank | Stock | Bias | Risk | Reason |
|---|---|---|---|---|
| 🥇 | NU | 🟢 Strong Bullish | Medium | Growth + profitability |
| 🥈 | USAS | 🟢 Bullish | High | Revenue + production |
| 🥉 | BAP | 🟢 Bullish | Medium | EPS + revenue beat |
| 4 | CSAN | 🟢 Bullish | High | Major earnings surprise |
| 5 | QXO | 🟡 Bullish Speculative | High | Acquisition-driven scale |
| 6 | DGXX | 🟡 Speculative | Very High | AI infrastructure |
| 7 | HSDT | 🟡 Speculative | Very High | SOL exposure |
| 8 | FATE/FDMT | 🟡 Biotech | Very High | Clinical catalysts |
| 9 | BALY | 🟡 Event Driven | High | Revenue beat, EPS miss |
| 10 | OTLK | 🟡 Event Driven | Very High | LYTENAVA launch |
| 11 | NKTR | 🟡 Speculative | Very High | EPS beat/pipeline |
| 12 | MSADY | 🟢 Moderate | Medium | Insurance growth |
| 13 | KLC | 🔴 Cautious | Medium | Weak EPS |
| 14 | STNE | 🔴 Bearish | High | Revenue miss |
| 15 | SGML | 🟡 Contrarian | High | Operational strength vs. earnings miss |
| 16 | YSS | 🔴 Bearish | Very High | EPS miss |
| 17 | GLOB | 🔴 Bearish | High | Guidance deterioration |
📌 Bottom Line
August 14 was less about headline EPS beats and more about the quality of the growth.
🟢 NU: the standout — profitable growth is accelerating.
🟢 USAS: strong operating execution and metals exposure.
🟢 BAP: clean financial beat.
🟡 QXO: enormous revenue growth, but acquisition/debt risk is rising.
🟡 DGXX/HIVE: AI infrastructure stories where future revenue matters more than today’s earnings.
🔴 GLOB: guidance overwhelmed the current-quarter numbers.
🔴 SGML: excellent operations weren’t enough to overcome the revenue miss.
Overall StockInsight™ Earnings Bias: 🟢 Constructive, but increasingly selective.
The broader market also finished the week near record territory, with the S&P 500 down only 0.17% Friday after Thursday’s record close. Strong corporate earnings continued to support equities even as investors weighed weak retail sales, higher oil prices and interest-rate uncertainty. (Reuters)
#StockInsight #Earnings #EarningsRecap #August14 #NU #NuHoldings #BAP #Credicorp #QXO #STNE #StoneCo #GLOB #Globant #SGML #SigmaLithium #USAS #DGXX #DigiPowerX #OTLK #OutlookTherapeutics #HIVE #HSDT #BALY #FATE #NKTR #StockMarket #WallStreet #Investing #Trading #EarningsSeason #AIInfrastructure
